Abstract
We thank Dr. Kellinghaus and colleagues for sharing their experience of a large cohort of patients with status epilepticus in Europe. Their finding that patients in the SENSE registry are similarly not receiving the recommended initial benzodiazepine dose highlights the systemic nature of the problem: patients with status epilepticus are being undertreated.1
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.